Back to Search
MICHAEL WILCOX, M.D.
Surgery Physician
NPI: 1689618803IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
10697(MT)
Education
UNIFORMED SERVICES UHS FE HEBERT SCHOOL OF MED
Class of 1991
Research & Publications (20)
An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota.
PMID 19617766·Dis Colon Rectum·2009
4-observational
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
PMID 19072714·Clin Infect Dis·2009
3-trial
Critical Care Canada Forum 2008, 11-13 November 2008, Toronto, Ontario, Canada.
PMID 19226442·Crit Care·2009
8-other
The tide of antimicrobial resistance and selection.
PMID 19596111·Int J Antimicrob Agents·2009
6-review
A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection.
PMID 19126333·Ann R Coll Surg Engl·2009
8-other
Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model.
PMID 18710908·Antimicrob Agents Chemother·2009
8-other
Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.
PMID 19112083·J Antimicrob Chemother·2009
8-other
Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infection.
PMID 19223641·Antimicrob Agents Chemother·2009
7-preclinical
Recent initiatives to reduce the spread of meticillin-resistant Staphylococcus aureus.
PMID 19584782·Br J Hosp Med (Lond)·2009
6-review
Clostridium difficile infection: new developments in epidemiology and pathogenesis.
PMID 19528959·Nat Rev Microbiol·2009
6-review
Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut model.
PMID 19211576·J Antimicrob Chemother·2009
8-other
Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
PMID 18491959·Clin Infect Dis·2008
8-other
Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.
PMID 18445577·J Antimicrob Chemother·2008
6-review
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
PMID 18606787·J Antimicrob Chemother·2008
8-other
Malignant clear cell hidradenoma of the vulva: report of a unique case and review of the literature.
PMID 18156989·Int J Gynecol Pathol·2008
5-case
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.
PMID 18761903·Euro Surveill·2008
8-other
A case-control study of community-associated Clostridium difficile infection.
PMID 18434341·J Antimicrob Chemother·2008
8-other
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
PMID 18772161·J Antimicrob Chemother·2008
4-observational
Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
PMID 18378719·Antimicrob Agents Chemother·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2900 12TH AVE N, SUITE 355W
BILLINGS, MT 59101 - Phone
- (406) 238-6470
Quick Facts
- NPI
- 1689618803
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile